article thumbnail

Legislation To Produce And Research Cannabis Introduced

NORML

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. .

article thumbnail

Weekly Legislative Roundup 1/4/19

NORML

Happy New Year and welcome to the first Weekly Legislative Roundup of 2019! Following are the bills that we’ve tracked this week and as always, check NORML’s Action Center for legislation pending in your state. Jake Wheatley (D), plan to file marijuana legalization bills in their respective chambers this legislative session.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Weekly Legislative Roundup 1/18/19

NORML

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Click here to email your Representative and urge them to support this important legislation.

article thumbnail

Harvard Is Launching America’s First Psychedelics Law and Policy Center

SpeedWeed

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . Harvard’s new center will be the first to focus solely on psychedelics policy and laws rather than research, though. View original article.

Policy 52
article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

article thumbnail

Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Cannabis Law Report

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).

Law 59
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. This legislation from Del. Missouri Rep. Texas This year, Texas Gov.